Exercise4

Hinge Health, Inc.

Total Value

Filing Date

Jul 29, 2026

1 transactions

Trade Summary

On Jul 27, 2026, Perez Daniel Antonio, Insider, reported $0 of Hinge Health, Inc. (HNGE) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Perez Daniel Antonio
Role: Insider
Location: SAN FRANCISCO, CA

Filing Details

Filing Date: Jul 29, 2026
Transaction Date: Jul 27, 2026
Accession Number: 0002063236-26-000012
Form Type: 4

Derivative Transactions

Date	Security	Shares	Exercise Price	Type	Value
Jul 27, 2026	HNGE derivative	944,250	—	Grant/Award	—
Jul 27, 2026	HNGE derivative	944,250	—	Exercise	—
Jul 27, 2026	HNGE derivative	944,250	—	Exercise	—
Jul 27, 2026	HNGE derivative	509,423	—	Tax Withholding	—

Want live alerts when Perez Daniel Antonio trades again?

Download Insider Trades to track HNGE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement.
(F2)The PSUs were earned and became vested upon the achievement of performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on July 27, 2026.
(F3)PSUs do not expire; they either vest or are cancelled prior to vesting date.
(F4)Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
(F5)Excludes 3,777,002 PSUs held by the Reporting Person.
(F6)Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Perez Daniel Antonio

(Last)

(First)

(Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO

94015

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & Co-Founder

3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance-based Restricted Stock Units	⁽¹⁾	07/27/2026		A		944,250		⁽²⁾	⁽³⁾	Class B Common Stock	944,250	$0	944,250	D
Performance-based Restricted Stock Units	⁽¹⁾	07/27/2026		M			944,250	⁽²⁾	⁽³⁾	Class B Common Stock	944,250	$0	0	D
Class B Common Stock	⁽⁴⁾	07/27/2026		M		944,250		⁽⁴⁾	⁽⁴⁾	Class A Common Stock	944,250	$0	10,433,095⁽⁵⁾	D
Class B Common Stock	⁽⁴⁾	07/27/2026		F⁽⁶⁾			509,423	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	509,423	$74.31	9,923,672	D
Class B Common Stock	⁽⁴⁾							⁽⁴⁾	⁽⁴⁾	Class A Common Stock	358,445		358,445	I	By Spouse

Explanation of Responses:

1. Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement.

2. The PSUs were earned and became vested upon the achievement of performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on July 27, 2026.

3. PSUs do not expire; they either vest or are cancelled prior to vesting date.

4. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

5. Excludes 3,777,002 PSUs held by the Reporting Person.

6. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

	/s/ James Budge, Attorney-in-Fact	07/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0002063236-26-000012.

Hinge Health, Inc.

Trade Summary

Company Information

Insider Information

Filing Details

Derivative Transactions

Want live alerts when Perez Daniel Antonio trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4